Abstract
Objectives
To correlate MR findings with pathology in steatotic FNHs and to compare the MR findings with those of other fatty tumours developed on noncirrhotic liver in a consecutive series of resected lesions.
Methods
Our population included resected FNH with intralesional steatosis (n = 25) and other resected fatty tumours selected as controls (hepatocellular adenomas and angiomyolipomas, n = 34). Lesions were classified into three groups: those with typical FNH without (group 1) or with (group 2) fat on MR and those with atypical lesions (group 3). In group 3, diagnostic criteria for other fatty tumours were applied.
Results
There were 9 lesions in group 1 (15.3 %), 4 in group 2 (16.8 %) and 46 in group 3 (77.9 %). Group 3 contained 12 FNHs (26 %) and all the other fatty tumours. In group 3, the association of lesion homogeneity, signal intensity similar to or slightly different from adjacent liver on in-phase T1- and T2-weighted sequences, and strong arterial enhancement was observed in 7/12 (58 %) of steatotic FNHs and 3/34 (9 %) of other tumours.
Conclusion
On MR, fat within a typical FNH should not reduce the diagnostic confidence. We recommend further investigations including liver biopsy if necessary when fatty tumours exhibit atypical MR findings.
Key Points
• MRI is increasingly used to assess hepatic lesions containing fat.
• Nodules of focal nodular hyperplasia often contain foci of fat.
• However, steatotic FNH does not always demonstrate typical fatty features on MRI.
• The main mimickers of steatotic FNHs are telangiectatic/inflammatory hepatocellular adenomas.
• We recommend liver biopsy when fatty tumours exhibit atypical MR findings.
Similar content being viewed by others
Abbreviations
- FNH:
-
Focal nodular hyperplasia
- HCA:
-
Hepatocellular adenoma
- LFABP:
-
Liver fatty acid-binding protein
- SAA:
-
Serum amyloid A
- GS:
-
Glutamine synthetase
- MRI:
-
Magnetic resonance imaging
- H&E:
-
Haematoxylin-eosin
References
Paradis V, Benzekri A, Dargère D et al (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329
Gaffey MJ, Iezzoni JC, Weiss LM (1996) Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 148:1089–1096
Rebouissou S, Bioulac-Sage P, Zucman-Rossi J (2008) Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48:163–170
Dokmak S, Paradis V, Vilgrain V et al (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705
Farges O, Ferreira N, Dokmak S et al (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89
Weimann A, Ringe B, Klempnauer J et al (1997) Benign liver tumours: differential diagnosis and indications for surgery. World J Surg 21:983–990
Vilgrain V (2006) Focal nodular hyperplasia. Eur J Radiol 58:236–245
Bioulac-Sage P, Balabaud C, Bedossa P et al (2007) Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 46:521–527
Prasad SR, Wang H, Rosas H et al (2005) Fat-containing lesions of the liver: radiologic–pathologic correlation. RadioGraphics 25:321–331
Basaran C, Karcaaltincaba M, Akata D et al (2005) Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR Am J Roentgenol 184:1103–1110
Valls C, Iannacconne R, Alba E et al (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308
Bioulac-Sage P, Rebouissou S, Thomas C et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748
Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524
van Aalten SM, Thomeer MG, Terkivatan T et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181
Ronot M, Bahrami S, Calderaro J et al (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191
Laumonier H, Bioulac-Sage P, Laurent C et al (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818
Högemann D, Flemming P, Kreipe H, Galanski M (2001) Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. Eur Radiol 11:1389–1395
Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK (1999) CT and MR imaging of benign hepatic and biliary tumours. RadioGraphics 19:431–451
Bioulac-Sage P, Laumonier H, Rullier A et al (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 29:459–465
Bioulac-Sage P, Cubel G, Balabaud C et al (2011) Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 31:91–103
Makhlouf HR, Abdul-Al HM, Goodman ZD (2005) Diagnosis of focal nodular hyperplasia of the liver by needle biopsy. Hum Pathol 36:1210–1216
Ferlicot S, Kobeiter H, Tran Van Nhieu J et al (2004) MRI of atypical focal nodular hyperplasia of the liver: radiology–pathology correlation. AJR Am J Roentgenol 182:1227–1231
Chaoui A, Mergo PJ, Lauwers GY (1998) Unusual appearance of focal nodular hyperplasia with fatty change. AJR Am J Roentgenol 171:1433–1434
Mathieu D, Paret M, Mahfouz AE et al (1997) Hyperintense benign liver lesions on spin-echo TI weighted MR images: pathologic correlations. Abdom Imaging 410–417
Mitchell DG, Palazzo J, Hann HW, Rifkin MD et al (1991) Hepatocellular tumours with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 15:762–769
Eisenberg LB, Warshauer DM, Woosley JT et al (1995) CT and MRI of hepatic focal nodular hyperplasia with peripheral steatosis. J Comput Assist Tomogr 19:498–500
Hussain SM, Terkivatan T, Zondervan PE et al (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. RadioGraphics 24:3–17
Grazioli L, Morana G, Kirchin MA et al (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177
Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529
Stanley G, Jeffrey RB Jr, Feliz B (2002) CT findings and mistopathology of intratumoural steatosis in focal nodular hyperplasia: case report and review of the literature. J Comput Assist Tomogr 26:815–817
Paradis V, Champault A, Ronot M et al (2007) Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 46140–46146
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ronot, M., Paradis, V., Duran, R. et al. MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol 23, 914–923 (2013). https://doi.org/10.1007/s00330-012-2676-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-012-2676-y